The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Nuvation Bio Inc.’s current trading price is -47.33% away from its 52-week high, while its distance from the 52-week low is -4.17%. The stock’s price range for this period has been between $1.44 and $2.62 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.05 million for the day, a number notably higher than the average daily volume of 0.46 million over the last three months.
Nuvation Bio Inc. (NUVB) stock is currently valued at $1.38. During the last session, the stock experienced a remarkable rise, reaching $1.46 after opening at $1.44. The stock briefly dropped to $1.36 before ultimately closing at $1.44.
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Nuvation Bio Inc. ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $2.62 on 01/27/23, while the lowest value for the same period was recorded at $1.44 on 09/14/23.
Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis
Nuvation Bio Inc. (NUVB) has experienced a quarterly decline of -21.14% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 304.04M and boasts a workforce of 54 employees.
Analyzing Trading Volume and Moving Average Trends
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.7067, with a change in price of -0.4400. Similarly, Nuvation Bio Inc. recorded 452,344 in trading volume during the last 100 days, posting a change of -24.18%.
Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis
The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for NUVB stands at 0.00. Similarly, the long-term debt-to-equity ratio is also 0.00.
NUVB Stock Stochastic Average
As of today, Nuvation Bio Inc.’s raw stochastic average for the last 50 days stands at 2.60%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 5.56%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 4.94% and 5.96%, respectively.
NUVB Stock Price Performance Analysis
Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. Until today this year the stock’s price performance recorded a decrease of -28.12%. However, over the last six months, the performance has been stronger by -15.85%. The price of NUVB decreased -19.77% over the last 30 days. And in the last five days, it has fallen by -12.10%.
